欢迎来到《四川大学学报（医学版）》
高级检索
杨钿, 陈昶, 潘南方, 等. BRAF V600E和TERT启动子突变与甲状腺乳头状癌临床病理特征的关系[J]. 四川大学学报（医学版）, 2019, 50(6): 919-924.
引用本文: 杨钿, 陈昶, 潘南方, 等. BRAF V600E和TERT启动子突变与甲状腺乳头状癌临床病理特征的关系[J]. 四川大学学报（医学版）, 2019, 50(6): 919-924.
shu
YANG Tian, CHEN Chang, PAN Nan-fang, et al. BRAF V600E Mutation and TERT Promoter Mutation in Papillary Thyroid Carcinomas and Their Association with Clinicopathological Characteristics[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(6): 919-924.
Citation: YANG Tian, CHEN Chang, PAN Nan-fang, et al. BRAF V600E Mutation and TERT Promoter Mutation in Papillary Thyroid Carcinomas and Their Association with Clinicopathological Characteristics[J]. Journal of Sichuan University (Medical Sciences), 2019, 50(6): 919-924.
shu

BRAF V600E和TERT启动子突变与甲状腺乳头状癌临床病理特征的关系

BRAF V600E Mutation and TERT Promoter Mutation in Papillary Thyroid Carcinomas and Their Association with Clinicopathological Characteristics

    摘要
  • 摘要:
      目的  探讨鼠类肉瘤滤过性毒菌致癌同源体B1(BRAF)V600E和端粒酶逆转录酶(TERT)启动子突变与甲状腺乳头状癌(PTC)临床病理特征之间的关系。
      方法  采用聚合酶链式反应(PCR)直接测序检测326例PTC患者肿瘤组织的BRAF V600E和TERT启动子的突变情况，并分析其与临床病理特征之间的关系。
      结果  BRAFV600E突变率为82.52% (269/326)，TERT启动子突变率为3.37%(11/326)，其中C228T位点突变9例，C250T位点突变2例，BRAF V600E和TERT启动子同时突变者10例(3.07%)。单因素分析结果显示BRAF V600E基因突变与PTC患者年龄及是否肿瘤复发/远处转移有关(P＜0.05)，TERT启动子突变与患者年龄、肿瘤最大径、是否甲状腺腺外侵犯、T分期、AJCC分期及是否肿瘤复发/远处转移有关(P < 0.05)。BRAF V600E和TERT启动子同时突变与患者年龄、肿瘤最大径、是否甲状腺腺外侵犯、T分期及AJCC分期有关(P＜0.05)。
      结论  PTC患者肿瘤组织BRAF V600E和TERT启动子同时突变时提示肿瘤侵袭性高。

     

    Abstract:
      Objective  To explore the relationships of BRAF V600E and TERT promoter mutations with the clinicopathological features in papillary thyroid carcinoma (PTC).
      Methods  The mutations of BRAF V600E and TERT promoters were examined by PCR-direct sequencing in tumor tissues from 326 PTC patients, while the relationships between the gene mutations and clinicopathological features were analyzed.
      Results  BRAF V600E mutation was found in 269/326 (82.52%), and TERT promoter mutation in 11/326 (3.37%) of PTC patients. In site mutations of TERT promoter, 9 cases were C228T and 2 cases were C250T. Single factor analysis showed that BRAF V600E mutations were significantly associated with age and recurrence/distant metastasis of tumor (P < 0.05), while TERT promoter mutations were significantly associated with age, tumor size, extrathyroidal extension, T stage, AJCC stage and recurrence/distant metastasis of tumor (P < 0.05). Coexistence of BRAF V600E and TERT promoter mutations (BRAF+/TERT+) were particularly associated with age, tumor size, extrathyroidal extension, T stage and AJCC stage (P < 0.05).
      Conclusion  Coexistence of BRAF V600E and TERT promoter mutations in PTC shows more aggressive tumor behavior.

     

    • HTML全文
    • 参考文献(21)
    • 相关文章
    • 施引文献
  • 资源附件(0)
© 2019 《四川大学学报（医学版）》编辑部　版权所有 cc

开放获取 本文遵循知识共享署名—非商业性使用4.0国际许可协议（CC BY-NC 4.0），允许第三方对本刊发表的论文自由共享（即在任何媒介以任何形式复制、发行原文）、演绎（即修改、转换或以原文为基础进行创作），必须给出适当的署名，提供指向本文许可协议的链接，同时标明是否对原文作了修改；不得将本文用于商业目的。CC BY-NC 4.0许可协议详情请访问 https://creativecommons.org/licenses/by-nc/4.0

/

返回文章
返回